Moderna (MRNA) shares rallied on June 26 after the company detailed its future beyond COVID-19 at its highly anticipated ...

Moderna, Inc. MRNA shares are trading higher on Monday. This follows Friday’s gain of more than 12%. A classic ‘flag’ pattern ...

Jason is a general assignment reporter, with particular focus on genetic medicine and rare disease. Confidential tips can be sent on Signal at JasonMast.77. Among all the awards and mementos Moderna ...

The S&P 500 ended marginally lower on Friday, with a steep drop in AI-related chip stocks and sharp gains in Moderna and ...

Micron, Sandisk, and ON Semiconductor slide. Wall Street is dumping some of the stocks that have benefited most from the AI ...

The S&P 500 ended marginally lower on Friday (June 26), with a steep drop in AI-related chip stocks and sharp gains in ...

Wall Street showed mixed results with gains in healthcare stocks while AI chip stocks fell. Discover the latest market trends ...

Moderna (MRNA) stock jumps on Science Day pipeline update and FDA flu vaccine vote; see key catalysts, technical levels, and ...

Shares of Moderna (NASDAQ:MRNA | MRNA Price Prediction) are up 14% to $68 and change in afternoon trading Friday, extending a ...

The S&P 500 and the Nasdaq were on pace for steep weekly losses as chipmakers came under renewed selling pressure on Friday after a stellar run this quarter.

An FDA panel voted 9-0 that the benefits of Moderna’s mRNA-1010 flu vaccine outweigh risks for adults aged 50 and older.

Moderna shares were up more than 10% Friday after the biotech company revealed a new effort to make a treatment for autoimmune disorders and outlined several experimental drug projects that could help ...